ナビゲーションをスキップする

ここから本文です。

英文論文業績 2017年

  1. Sakamoto Y, Kokudo N, Watadani T, Shibahara J, Yamamoto M, Yamaue H;
    Japanese Society of Hepato-Biliary-Pancreatic Surgery:
    Proposal of size-based surgical indication criteria for liver hemangioma based
    on a nationwide survey in Japan.
    J Hepatobiliary Pancreat Sci 24(7):417-25, 2017

  2. Hayata K, Nakamori M, Nakamura M, Ojima T, Iwahashi M, Katsuda M, Tsuji T, Kato T, Kitadani J, Takeuchi A, Tabata H, Yamaue H:
    Circular stapling versus triangulating stapling for the cervical esophagogastric anastomosis
    after esophagectomy in patients with thoracic esophageal cancer: A prospective, randomized, controlled trial.
    Surgery 162(1):131-8, 2017
  3. Uraki S, Ariyasu H, Doi A, Furuta H, Nishi M, Usui T, Yamaue H, Akamizu T:
    Hypersecretion of ACTH and PRL from pituitary adenoma in MEN1, adequately managed by medical therapy.
    Endocrinol Diabetes Metab Case Rep. pii: 17-0027. doi: 10.1530/EDM-17-0027. eCollection 2017
  4. Otsubo T, Kobayashi S, Sano K, Misawa T, Ota T, Katagiri S, Yanaga K, Yamaue H, Kokudo N, Unno M,
    Fujimoto J, Miura F, Miyazaki M, Yamamoto M:
    Safety-related outcomes of the Japanese Society of Hepato-Biliary-Pancreatic Surgery board certification system
    for expert surgeons.
    J Hepatobiliary Pancreat Sci 24(5):252-61, 2017
  5. Ojima T, Nakamori M, Nakamura M, Katsuda M, Hayata K, Kato T, Kitadani J, Tabata H, Takeuchi A, Yamaue H:
    Randomized clinical trial of landiolol hydrochloride for the prevention of atrial fibrillation
    and postoperative complications after oesophagectomy for cancer.
    Br J Surg 104(8):1003-9, 2017
  6. Yokoe M, Takada T, Hwang TL, Endo I, Akazawa K, Miura F, Mayumi T, Mori R, Chen MF, Jan YY, Ker CG, Wang HP,
    Itoi T, Gomi H, Kiriyama S, Wada K, Yamaue H, Miyazaki M, Yamamoto M:
    Validation of TG13 severity grading in acute cholecystitis: Japan-Taiwan collaborative study for acute cholecystitis.
    J Hepatobiliary Pancreat Sci 24(6):338-45, 2017
  7. Kiriyama S, Takada T, Hwang TL, Akazawa K, Miura F, Gomi H, Mori R, Endo I, Itoi T, Yokoe M, Chen MF, Jan YY,
    Ker CG, Wang HP, Yamaue H, Miyazaki M, Yamamoto M:
    Clinical application and verification of the TG13 diagnostic and severity grading criteria for acute cholangitis:
    An international multicenter observational study.
    J Hepatobiliary Pancreat Sci 24(6):329-37, 2017
  8. Endo I, Takada T, Hwang TL, Akazawa K, Mori R, Miura F, Yokoe M, Itoi T, Gomi H, Chen MF, Jan YY, Ker CG,
    Wang HP, Kiriyama S, Wada K, Yamaue H, Miyazaki M, Yamamoto M:
    Optimal treatment strategy for acute cholecystitis based on predictive factors: Japan-Taiwan multicenter cohort study.
    J Hepatobiliary Pancreat Sci 24(6):346-61, 2017
  9. Itoi T, Takada T, Hwang TL, Endo I, Akazawa K, Miura F, Chen MF, Jan YY, Ker CG, Wang HP, Gomi H, Yokoe M, Kiriyama S, Yamaue H, Miyazaki M, Yamamoto M:
    Percutaneous and endoscopic gallbladder drainage for the acute cholecystitis: International multicenter comparative
    study by a propensity score-matched analysis.
    J Hepatobiliary Pancreat Sci 24(6):362-8, 2017
  10. Gomi H, Takada T, Hwang TL, Akazawa K, Mori R, Endo I, Miura F, Kiriyama S, Matsunaga N, Itoi T, Yokoe M, Chen MF, Jan YY, Ker CG, Wang HP, Wada K, Yamaue H, Miyazaki M, Yamamoto M:
    Updated comprehensive epidemiology, microbiology, and outcomes among patients with acute cholangitis.
    J Hepatobiliary Pancreat Sci 24(6):310-8, 2017
  11. Yokoe M, Takada T, Hwang TL, Endo I, Akazawa K, Miura F, Mayumi T, Mori R, Chen MF, Jan YY, Ker CG, Wang HP, Itoi T, Gomi H,
    Kiriyama S, Yamaue H, Miyazaki M, Yamamoto M:
    Descriptive review of acute cholecystitis: Japan-Taiwan collaborative epidemiological study.
    J Hepatobiliary Pancreat Sci 24(6):319-28, 2017
  12. Hotta T, Takifuji K, Yokoyama S, Matsuda K, Ieda J, Watanabe T, Tamura K, Mitani Y, Iwamoto H, Takei Y, Mizumoto Y, Tsumura A, Deguchi M, Yamaue H:
    Horizontal rectal transection using an endolinear stapler for laparoscopic low anterior resection.
    Tech Coloproctol 21(4):311-13, 2017

  13. Ueno M, Kawai M, Hayami S, Hirono S, Okada KI, Uchiyama K, Yamaue H:
    Partial clamping of the infrahepatic inferior vena cava for blood loss reduction during anatomic liver resection:
    A prospective, randomized, controlled trial.
    Surgery 161(6):1502-13, 2017
  14. Ojima T, Nakamori M, Nakamura M, Katsuda M, Hayata K, Matsumura S, Iwahashi M, Yamaue H:
    Phase I/II study of divided-dose docetaxel, cisplatin and fluorouracil for patients with recurrent or metastatic squamous cell carcinoma of the esophagus.
    Dis Esophagus 30(2):1-7, 2017
  15. Yamaue H, Shimizu A, Hagiwara Y, Sho M, Yanagimoto H, Nakamori S, Ueno H, Ishii H, Kitano M, Sugimori K,
    Maguchi H, Ohkawa S, Imaoka H, Hashimoto D, Ueda K, Nebiki H, Nagakawa T, Isayama H, Yokota I, Ohashi Y, Shirasaka T:
    Multicenter, randomized, open-label Phase II study comparing S-1 alternate-day oral therapy with the standard daily regimen
    as a first-line treatment in patients with unresectable advanced pancreatic cancer.
    Cancer Chemother Pharmacol. 79(4):813-23, 2017
  16. Hirono S, Kawai M, Okada KI, Miyazawa M, Shimizu A, Kitahata Y, Ueno M, Yanagisawa A, Yamaue H:
    Factors Associated With Invasive Intraductal Papillary Mucinous Carcinoma of the Pancreas.
    JAMA Surg 152(3):e165054, 2017
  17. Okada KI, Hirono S, Kawai M, Miyazawa M, Shimizu A, Kitahata Y, Ueno M, Hayami S, Kojima F, Yamaue H:
    Value of apparent diffusion coefficient prior to neoadjuvant therapy is a predictor of histologic response
    in patients with borderline resectable pancreatic carcinoma.
    J Hepatobiliary Pancreat Sci 24(3):161-8, 2017
  18. Okada KI, Hirono S, Kawai M, Miyazawa M, Shimizu A, Kitahata Y, Ueno M, Hayami S, Yamaue H:
    Phase I Study of Nab-Paclitaxel plus Gemcitabine as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer.
    Anticancer Res 37(2):853-858, 2017
  19. Takada Y, Kaido T, Shirabe K, Nagano H, Egawa H, Sugawara Y, Taketomi A, Takahara T, Wakabayashi G, Nakanishi C, Kawagishi N, Kenjo A, Gotoh M, Toyoki Y, Hakamada K, Ohtsuka M, Akamatsu N, Kokudo N,Takeda K, Endo I, Takamura H, Okajima H, Wada H, Kubo S, Kuramitsu K, Ku Y, Ishiyama K, Ohdan H, Ito E,Maehara Y, Honda M, Inomata Y, Furukawa H, Uemoto S, Yamaue H, Miyazaki M, Takada T;LTx-PET study group of the Japanese Society of Hepato-Biliary-Pancreatic Surgery,the Japanese Liver Transplantation Society:
    Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrenceafter liver transplantation for hepatocellular carcinoma patients: A Japanese multicenter study.
    J Hepatobiliary Pancreat Sci 24(1):49-57, 2017
  20. Furuta M, Ueno M, Fujimoto A, Hayami S, Yasukawa S, Kojima F, Arihiro K, Kawakami Y, Wardell CP, Shiraishi Y, Tanaka H, Nakano K, Maejima K, Sasaki-Oku A, Tokunaga N, Boroevich KA, Abe T, Aikata H, Ohdan H, Goto K, Kubo M, Tsunoda T, Miyano S, Chayama K, Yamaue H, Nakagawa H:
    Whole genome sequencing discriminate hepatocellular carcinoma with intrahepatic metastasis from multicentric tumors.
    J Hepatol 66(2):363-73, 2017
  21. Miyazawa M, Katsuda M, Maguchi H, Katanuma A, Ishii H, Ozaka M, Yamao K, Imaoka H, Kawai M, Hirono S, Okada KI, Yamaue H:
    Phase II clinical trial using novel peptide cocktail vaccine as a postoperative adjuvant treatment for surgically resected pancreatic cancer patients.
    Int J Cancer 140(4):973-82, 2017 (Feb)
  22. Ojima T, Nakamori M, Nakamura M, Katsuda M, Hayata K, Nakamura Y, Yamaue H:
    Expression of BRCA1, a factor closely associated with relapse-free survival, in patientswho underwent neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil for squamous cell carcinoma of the esophagus.
    Surg Today 47(1):65-73, 2017